Ingredient

Teneligliptin Hydrobromide Hydrate

Teneligliptin hydrobromide monohydrate is a blood glucose control ingredient used in the treatment of type 2 diabetes.

See medicines used for Chronic Conditions
All medicines
4
Single ingredient
1
Combination
3
Prescription medication
4

MFDS ingredient code M259364

What does it do?

Teneligliptin hydrobromide monohydrate is a diabetic agent belonging to the DPP-4 inhibitor class. This ingredient is used in medications to promote insulin secretion and lower blood glucose levels.

This ingredient increases insulin secretion and inhibits blood glucose elevation by suppressing the degradation of incretin hormones in the body. This helps prevent excessive blood glucose rises after meals.

Commonly used for

Approved uses differ by product. Check each product's information for its actual use.

Good to know

Compared to other DPP-4 inhibitors, teneligliptin has higher selectivity and a longer half-life, allowing it to maintain effectiveness with once-daily dosing. Additionally, the blood glucose-lowering effect is stable and has a relatively low risk of hypoglycemia.

Medicines containing this ingredient

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Category
Dosage form
Strength
Category

4 total

Even with the same ingredient, dosage and approved uses can differ by strength, dosage form and combined ingredients. Check each product's information before taking it.

Combined ingredients

Ingredients used together with this ingredient in combination products.

Questions about this ingredient

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

SourceKorea Ministry of Food and Drug Safety (Drug Safety Korea)

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.